With GENE to GMP™ in 9 Months, we can help you achieve faster time-to-market, lower manufacturing costs and can rescue your promising drug candidates.
In June 2017, JSR Life Sciences acquired Selexis as part of JSR’s commitment to offer industry partners best-in-class contract development manufacturing (CDMO) services. Selexis SA and KBI Biopharma, which was acquired by JSR in 2015, have joined forces to provide industry partners “GENE to GMP in 9 Months” — the most robust and fastest service offering for the biopharmaceutical industry.
With GENE to GMP in 9 months, we are committed to our partners’ satisfaction. By predictably getting cGMP material for your clinical study, we help you concentrate on the other critical components of your development program.
